“Receiving the MedTech Breakthrough Award for Genius AI Detection PRO is an honor and a testament to our team’s unwavering commitment to relentless innovation in women's health,” said Mark Horvath, President of Breast and Skeletal Health Solutions. “Guided by ongoing feedback from our customers and the radiologist community, we will continue to advance this AI technology, bringing even greater accuracy and efficiency to the reading workflow and supporting better outcomes for patients.”

Breast cancer has a five-year survival rate of about 99% when caught early,¹ so regular mammography screenings remain key to detecting the disease when it’s most treatable. The use of artificial intelligence (AI) to interpret the results of these tests is rapidly becoming an important tool for physicians in the fight against breast cancer.

Trained using large, high-quality databases of mammograms, including both benign and biopsy-proven cancers, the Genius AI Detection PRO algorithm looks at 2D and 3D mammography images and detects areas that are suspicious for breast cancer. Each detected finding receives a score from 1 to 10, where the higher the score, the higher the level of suspicion for cancer. For each mammogram the AI-powered technology presents individual scores for each finding, an overall score per breast and an overall score per case for radiologists' review.

The new Genius AI Detection PRO solution — which expands on Hologic’s flagship Genius AI Detection 2.0 Solution — brings to bear intuitive case and lesion scoring and pre-populated exam reports designed to accelerate image review and save radiologists’ time. It offers a deep-learning 2D and 3D algorithm that improves specificity³ by using a patient’s prior exam in the current exam’s analysis, and an all-in-one interface that conveniently includes deep-learning breast density scoring along with key patient and mammogram quality information.²

To further aid radiologists in assessing cases, the Genius AI Detection PRO integrates a red-yellow-green color-coding system.² Green cases signify that the AI has assessed a low likelihood of breast cancer, while red indicates a high likelihood. This intuitive scoring system was shown to reduce radiologists’ overall reading time by 24%.² The AI platform also helps with interoperability by offering an all-in-one user interface² through an application that can be loaded onto any reading workstation.

This year’s MedTech Breakthrough Awards program saw a record-breaking number of nominations from leading companies and startups across more than 18 countries. As a global leader in women’s health, Hologic is honored to receive this award and remains committed to pushing the boundaries of science to define the future of breast cancer screening and reduce the burden of this disease that impacts so many lives.

Learn more about Genius AI Detection PRO.

About Hologic, Inc. 

Hologic, Inc. is a global leader in women’s health dedicated to developing innovative medical technologies that effectively detect, diagnose and treat health conditions and raise the standard of care around the world. To learn more, visit www.hologic.com and connect with us on LinkedIn, Facebook, X, Instagram and YouTube. 

Forward-Looking Statements 

This news release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic products. There can be no assurance these products will achieve the benefits described herein or that such benefits will be replicated in any particular manner with respect to an individual patient, as the actual effect of the use of the products can only be determined on a case-by-case basis. In addition, there can be no assurance that these products will be commercially successful or achieve any expected level of sales. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such data or statements are based. 

Hologic, The Science of Sure and Genius AI are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries. 

Media Contact 
Bridget Perry
Senior Director, Corporate Communications 
(+1) 508.263.8654
bridget.perry@hologic.com 

Investor Contact 
Michael Watts 
Corporate Vice President, Investor Relations 
(+1) 858.410.8514 
michael.watts@hologic.com

SOURCE: Hologic, Inc.